| |  Online-Ressource |
|---|
| Verfasst von: | Rottmann, Felix [VerfasserIn]  |
|---|
| | Breiden, Ann Katrin [VerfasserIn] |
|---|
| | Bemtgen, Xavier [VerfasserIn] |
|---|
| | Welte, Thomas [VerfasserIn] |
|---|
| | Supady, Alexander [VerfasserIn] |
|---|
| | Wengenmayer, Tobias [VerfasserIn] |
|---|
| | Staudacher, Dawid [VerfasserIn] |
|---|
| Titel: | Levosimendan in acute heart failure with severely reduced kidney function, a propensity score matched registry study |
|---|
| Verf.angabe: | Felix Arne Rottmann, Ann Katrin Breiden, Xavier Bemtgen, Thomas Welte, Alexander Supady, Tobias Wengenmayer and Dawid Leander Staudacher |
|---|
| E-Jahr: | 2022 |
|---|
| Jahr: | 20 October 2022 |
|---|
| Umfang: | 12 S. |
|---|
| Fussnoten: | Gesehen am 25.01.2023 |
|---|
| Titel Quelle: | Enthalten in: Frontiers in Cardiovascular Medicine |
|---|
| Ort Quelle: | Lausanne : Frontiers Media, 2014 |
|---|
| Jahr Quelle: | 2022 |
|---|
| Band/Heft Quelle: | 9(2022), Artikel-ID 1027727, Seite 1-12 |
|---|
| ISSN Quelle: | 2297-055X |
|---|
| Abstract: | Patients with heart failure frequently present with kidney dysfunction. Kidney function is relevant, as prognosis declines with reduced kidney function and potentially beneficial drugs like levosimendan are contraindicated for missing safety data.Materials and methodsA single-center retrospective registry study was conducted including all patients receiving levosimendan on a medical intensive care unit between January 2010 and December 2019. Exclusion criteria were a follow-up less than 24 h or missing glomerular filtration rate (eGFR) before administration of levosimendan. The first course of treatment was evaluated. Patients were stratified by eGFR before drug administration and the primary endpoint was a composite of supraventricular-, ventricular tachycardia and death within 7 days after administration of levosimendan. An internal control group was created by propensity score matching. |
|---|
| DOI: | doi:10.3389/fcvm.2022.1027727 |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.3389/fcvm.2022.1027727 |
|---|
| | Volltext: https://www.frontiersin.org/articles/10.3389/fcvm.2022.1027727 |
|---|
| | DOI: https://doi.org/10.3389/fcvm.2022.1027727 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| K10plus-PPN: | 1832395154 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
Levosimendan in acute heart failure with severely reduced kidney function, a propensity score matched registry study / Rottmann, Felix [VerfasserIn]; 20 October 2022 (Online-Ressource)
